Correlates of survival after autoantibody reduction therapy for acute IPF exacerbations.
<h4>Background</h4>No medical treatment has proven efficacy for acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF), and this syndrome has a very high mortality. Based on data indicating humoral autoimmune processes are involved in IPF pathogenesis, we treated AE-IPF patients w...
Saved in:
| Main Authors: | Tejaswini Kulkarni, Vincent G Valentine, Fei Fei, Thi K Tran-Nguyen, Luisa D Quesada-Arias, Takudzwa Mkorombindo, Huy P Pham, Sierra C Simmons, Kevin G Dsouza, Tracy Luckhardt, Steven R Duncan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0260345&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intrapulmonary Autoantibodies to HSP72 Are Associated with Improved Outcomes in IPF
by: Ross Mills, et al.
Published: (2019-01-01) -
Interaction mechanism between blockchain and IPFS
by: Feng Yang, et al.
Published: (2023-07-01) -
Comorbidities’ Effect on IPF: Pathogenesis and Management
by: Andrea Salotti, et al.
Published: (2025-06-01) -
Bexotegrast in people with idiopathic pulmonary fibrosis (IPF): a plain language summary of publication of the INTEGRIS-IPF study
by: Lisa Lancaster, et al.
Published: (2024-11-01) -
Coexistence of CN1A autoantibodies in GAD65 encephalitis exacerbates neurodegeneration
by: Annika Breuer, et al.
Published: (2025-07-01)